Clinical trials: Condom Use
Condom Use
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
This study is a masked (investigators, research staff), two-way crossover, randomized to sequence of use study designed to evaluate the acceptability and functional performance (breakage, slippage) of a silicone lubricated…
- Trial name
- NCT06595836
- Testing
- Silicone Lubricated Synthetic polyisoprine condom, Silicone Lubricated Natural Rubber Latex Condom
- Where
- 2 sites in United States
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- Thai Nippon Rubber Industry Public Company Limited
Infertility
Usability Study of the Focus Touch™ Conception System: Semen Collection
This is a human factors usability study designed to validated usability by obtaining feedback in a home use environment regarding ease of use of the Focus Touch™ Conception System Conceptacle (when used to collect semen) and the…
- Trial name
- Ib2C (NCT01585012)
- Testing
- Cervical cap (Focus Touch™ Conception System)
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Rinovum Women's Health, Inc.
Condom Users
User Preference Study of an Experimental HydroGlyde Male Condom Compared to a Commercial Latex Male Condom
Latex condoms have long been available as contraceptive devices as well as an effective means of preventing the spread of sexually transmitted infections.
- Trial name
- NCT05308992
- Testing
- HydroGlyde Condom
- Where
- United States
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- HydroGlyde Coatings, LLC
COVID-19, Upper Respiratory Tract Infections
COVID-19 Prevention Trial: Effect of Prophylactic Use of TAFFIX™ on Infection Rate by SARS-CoV-2 Virus (COVID-19).
TAFFIX is a nasal powder spray that immediately creates a protective acidic barrier on the nasal mucosa against infection by inhaled viruses. The protective barrier lasts 5 hours.
- Trial name
- NCT05252468
- Testing
- TaffiX™
- Where
- Bulgaria
- Volunteers
- 693 people, healthy volunteers welcome
- Sponsor
- Nasus Pharma
Tolerance and Acceptability of a New Condom Coating
Evaluation of Tolerance and Acceptability of a Coated Condom
This Clinical Investigation is designed to provide tolerance, acceptability and safety data of a new condom coating, in its intended use to support future application for CE Mark.
- Trial name
- NCT01619397
- Testing
- Test condom with new Xanthan gum condom coating
- Where
- United Kingdom
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Reckitt Benckiser LLC
Pharmacokinetics, Safety Issues
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
A double-blind, randomized trial (1:1) to characterize the local and systemic pharmacokinetics (PK) of two DPV-LNG vaginal ring formulations
- Conditions
- Pharmacokinetics, Safety Issues, Bleeding
- Trial name
- NCT05041699
- Testing
- IPM Ring-105, IPM Ring-106
- Where
- 2 sites in United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- International Partnership for Microbicides, Inc.
Condom Use
Prospective, Verification Study to Assess Condom Fit Across Polyurethane (PU) and Natural Rubber Latex (NRL) Condoms
The investigation is to explore condom experience in terms of comfort and fit across a range of condom sizes and materials.
- Trial name
- NCT06777797
- Testing
- PU condoms (Test PU Condom A, Test PU Condom B, Test PU Condom C, Test PU Condom D), NRL condoms (Test NRL Condom A, Test NRL Condom B, Test NRL Condom C, Test NRL Condom D)
- Where
- Germany
- Volunteers
- 224 people, healthy volunteers welcome
- Sponsor
- Reckitt Benckiser Healthcare (UK) Limited